PROTECTODERM 20% 20 %
SILICONE : 20 % · DIN 00246042 · INGRAM AND BELL INC.
Health Canada status: CANCELLED POST MARKET
What is PROTECTODERM 20%?
PROTECTODERM 20% 20 % contains SILICONE : 20 %. It is listed in the Health Canada Drug Product Database under DIN 00246042, held by INGRAM AND BELL INC., supplied as OINTMENT for TOPICAL administration. Health Canada currently lists it as cancelled post market, status dated 05-Aug-1999. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00246042 |
|---|---|
| Brand name | PROTECTODERM 20% |
| Generic / active ingredient | SILICONE : 20 % |
| Manufacturer | INGRAM AND BELL INC. |
| Strength | 20 % |
| Dosage form | OINTMENT |
| Route of administration | TOPICAL |
| Schedule | NON-PRESCRIPTION DRUGS |
| ATC code | D02AA SILICONE PRODUCTS |
| AHFS class | 08:12.24 |
| Biosimilar | No |
| Health Canada status | CANCELLED POST MARKET |
| Status date | 05-Aug-1999 |
| Original market date | 1997-07-25 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code D02AA SILICONE PRODUCTS. 7 of 41 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| BARRIERE CREAM 20% | 20 % | CREAM | WELLSPRING PHARMACEUTICAL CANADA CORP | MARKETED | DIN 02060841 |
| BAZA CLEANSE & PROTECT | 2 % | LOTION | COLOPLAST A/S | MARKETED | DIN 02243966 |
| CAVILON DURABLE BARRIER CREAM | 1.3 % | CREAM | 3M HEALTHCARE CANADA COMPANY LIMITED | MARKETED | DIN 02455838 |
| CICAPLAST BAUME B5 CONDITIONING PRO-VITAMIN B5 PRO-VITAMINE B5 REVITALISANTE | 9 % | CREAM | LABORATOIRES LA ROCHE-POSAY CANADA | MARKETED | DIN 02527731 |
| COMFORT SHIELD | 3 % | WIPE | SAGE PRODUCTS LLC | MARKETED | DIN 02245871 |
| DIMETHICONE PROTECTANT | 5.0 % | CREAM | SMITH & NEPHEW INC | MARKETED | DIN 02301725 |
| PROSHIELD PLUS | 1 % | OINTMENT | SMITH & NEPHEW INC | MARKETED | DIN 02256975 |
| BABY FRESH WIPES WITH ULTRAGUARD 1% | 1 % | LOTION | SCOTT PAPER LIMITED | CANCELLED POST MARKET | DIN 02022761 |
| BARRIER CREME - 1.5% | 1.5 % | CREAM | HOLLISTER LIMITED | CANCELLED POST MARKET | DIN 02144522 |
| BARRIERE CRM 20% | 20 % | CREAM | ALLEN & HANBURYS A GLAXO CANADA LTD. CO. | CANCELLED POST MARKET | DIN 00253057 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.